Drugs / GSK 2115160A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00714285 | Jul 2008 → Jan 2009 | influenza | GlaxoSmithKline | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK 2115160A | “Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate GSK 2115160A in Adults.” NCT00714285 ↗ |
| Modality | Vaccine | “two candidate quadrivalent influenza vaccines” PMID 23688546 ↗ May 2013 |
| Route | Intramuscular | “Single intramuscular dose on Day 0.” NCT00714285 ↗ |